Atripla

The optimum dose of key antiretroviral drugs is often overlooked during product development. The ENCORE1 study compared the efficacy and...


The FDA ( Food and Drug Administration ) has approved Stribild ( Elvitegravir 150 mg / Cobicistat 150 mg /...


The FDA ( Food and Drug Administration ) has approved Atripla, a fixed-dose combination of three widely-used antiretroviral drugs, in...


Researchers at Johns Hopkins and other institutions has found that a once-daily combination of three antiretroviral drugs works better as...